Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804–2811

PubMed  Google Scholar 

Gassanov N, Caglayan E, Semmo N, Massenkeil G, Er F. Cirrhotic cardiomyopathy: a cardiologist’s perspective. World J Gastroenterol. 2014;20:15492–15498

PubMed  PubMed Central  Google Scholar 

Arroyo V, Angeli P, Moreau R, Jalan R, Claria J, Trebicka J, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2020;74:670–685

PubMed  Google Scholar 

Krag A, Bendtsen F, Burroughs AK, Møller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012;79:53–55

PubMed  Google Scholar 

Raevens S, Geerts A, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Colle I. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int. 2015;35:1646–1660

PubMed  Google Scholar 

Møller S, Bendtsen F. Cirrhotic multiorgan syndrome. Dig Dis Sci. 2015;60:3209–3225

PubMed  Google Scholar 

Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38:570–580

PubMed  Google Scholar 

Alvarado E, Garcia-Guix M, Mirabet S, Villanueva C. The relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis. J Hepatol. 2018;69:746–747

PubMed  Google Scholar 

Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, et al. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int. 2020;40:1457–1466

CAS  PubMed  Google Scholar 

Perello A, Inserte J, Godoy A, Puigfel Y, Garcia-Pagan JC, Garcia-Dorado D, et al. Cardiac structure and function in experimental intra-hepatic portal hypertension. J Hepatol. 2000;32:65

Google Scholar 

Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, Macgowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol. 2012;58:757–762

PubMed  Google Scholar 

Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425–439

PubMed  Google Scholar 

Izzy M, Oh J, Watt KD. Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander. Hepatology. 2018;68:10

Google Scholar 

Møller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol. 2019;13:10

Google Scholar 

Wehmeyer MH, Heuer AJ, Benten D, Puschel K, Sydow K, Lohse AW, et al. High rate of cardiac abnormalities in a postmortem analysis of patients suffering from Liver cirrhosis. J Clin Gastroenterol. 2015;49:866–872

PubMed  Google Scholar 

Younossi ZM, Henry L, Bush H, Mishra A. Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22:1–10

PubMed  Google Scholar 

Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, et al. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51:1149–1159

CAS  PubMed  Google Scholar 

Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69:1691–1705

CAS  PubMed  Google Scholar 

Vanwagner LB, Wilcox JE, Ning H, Lewis CE, Carr JJ, Rinella ME, et al. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: The CARDIA Study. J Am Heart Assoc. 2020;9: e014279

PubMed  PubMed Central  Google Scholar 

Brouwers MCGJ, Simons N, Stehouwer CDA, Isaacs A. Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. Diabetologia. 2020;63:253–260

CAS  PubMed  Google Scholar 

Isaak A, Praktiknjo M, Jansen C, Faron A, Sprinkart AM, Pieper CC, et al. Myocardial fibrosis and inflammation in liver cirrhosis: MRI Study of the liver-heart axis. Radiology. 2020;297:51–61

PubMed  Google Scholar 

Njoku DB, Schilling JD, Finck BN. Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver-heart crosstalk. Curr Opin Lipidol. 2022;33:295–299

CAS  PubMed  Google Scholar 

Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1–10

PubMed  Google Scholar 

Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep. 2021;3: 100316

PubMed  PubMed Central  Google Scholar 

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49-s66

CAS  PubMed  PubMed Central  Google Scholar 

Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol. 2021;75(Suppl 1):S36-s48

PubMed  Google Scholar 

Voiosu A, Wiese S, Voiosu T, Bendtsen F, Møller S. Bile acids and cardiovascular function in cirrhosis. Liver Int. 2017;37:1420–1430

CAS  PubMed  Google Scholar 

Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik J, Williamson C. Heart and bile acids—clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1345–1355

CAS  PubMed  Google Scholar 

Desai MS. Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy. Anal Biochem. 2021;636:114388

PubMed  Google Scholar 

Sorribas M, Jakob MO, Yilmaz B, Li H, Stutz D, Noser Y, et al. FxR-modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J Hepatol. 2019;71:1126–1140

CAS  PubMed  Google Scholar 

Bellot P, Garcia-Pagan JC, Frances R, Abraldes JG, Navasa M, Perez-Mateo M, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology. 2010;52:2044–2052

CAS  PubMed  Google Scholar 

Arab JP, Arrese M, Shah VH. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: current concepts and perspectives. Hepatol Res. 2020;50:407–418

PubMed  PubMed Central  Google Scholar 

Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72:558–577

CAS  PubMed  Google Scholar 

Arroyo V. Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome. Hepatol Int. 2017;11:242–244

PubMed  Google Scholar 

Coenraad MJ, Porcher R, Bendtsen F. Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango. J Hepatol. 2018;68:887–889

CAS  PubMed  Google Scholar 

Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018;15:753–764

CAS  PubMed  Google Scholar 

Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Caporali C, et al. Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis. J Hepatol. 2018;68:949–958

CAS  PubMed  Google Scholar 

Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med. 1958;102:405–413

CAS  PubMed  Google Scholar 

Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, et al. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24:425–432

CAS  PubMed  Google Scholar 

Ben Hammouda S, Grayaa M, Njima M, Mabrouk S, Boussaid M, Aissaoui A, et al. Sudden death due to cirrhotic cardiomyopathy: an autopsy case report. J Forensic Leg Med. 2022;89: 102369

PubMed  Google Scholar 

Jellis CL, Kwon DH. Myocardial T1 mapping: modalities and clinical applications. Cardiovasc Diagn Ther. 2014;4:126–137

PubMed  PubMed Central  Google Scholar 

Glenn TK, Honar H, Liu H, Keurs H, Lee SS. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol. 2011;55:1249–1255

CAS  PubMed  Google Scholar 

Honar H, Liu H, Zhang ML, Glenn TK, Ter Keurs HEDJ, Lee SS. Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy. Liver Int. 2020;40:2808–2819

CAS  PubMed  Google Scholar 

Liu H, Yoon KT, Zhang J, Lee SS. Advances in cirrhotic cardiomyopathy. Curr Opin Gastroenterol. 2021;37:187–193

CAS  PubMed  Google Scholar 

Cesari M, Frigo AC, Tonon M, Angeli P. Cardiovascular predictors of death in patients with cirrhosis. Hepatology. 2018;68:215–223

PubMed  Google Scholar 

Wiese S, Liang M, Mo S, Bendtsen F, Hove JD, Møller S. Left atrial volume changes assessed by real time 3-dimensional echocardiography in relation to liver function and prognosis in patients with cirrhosis. Int J Cardiovasc Imaging. 2020;36:2121–2127

PubMed  Google Scholar 

Rector WGJ, Hossack KF. Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished “effective” arterial blood volume? Gastroenterology. 1988;95:1658–1663

PubMed  Google Scholar 

Møller S, Søndergaard L, Møgelvang J, Henriksen O, Henriksen JH. Decreased right